135 related articles for article (PubMed ID: 37635016)
1. [Tyrosine kinase receptor gene fusion: A series of four cases of infantile-type hemispheric glioma].
Sourty B; Basset L; Michalak S; Colin E; Zidane-Marinnes M; Delion M; de Carli E; Rousseau A
Ann Pathol; 2023 Nov; 43(6):462-474. PubMed ID: 37635016
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma.
Tauziède-Espariat A; Beccaria K; Dangouloff-Ros V; Sievers P; Meurgey A; Pissaloux D; Appay R; Saffroy R; Grill J; Mariet C; Bourdeaut F; Hasty L; Métais A; Chrétien F; Blauwblomme T; Puget S; Boddaert N; Varlet P;
Brain Pathol; 2023 Sep; 33(5):e13182. PubMed ID: 37349135
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma.
Nakano Y; Tomiyama A; Kohno T; Yoshida A; Yamasaki K; Ozawa T; Fukuoka K; Fukushima H; Inoue T; Hara J; Sakamoto H; Ichimura K
Brain Tumor Pathol; 2019 Jan; 36(1):14-19. PubMed ID: 30350109
[TBL] [Abstract][Full Text] [Related]
4. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.
Meredith DM; Cooley LD; Dubuc A; Morrissette J; Sussman RT; Nasrallah MP; Rathbun P; Yap KL; Wadhwani N; Bao L; Wolff DJ; Ida C; Sukhanova M; Horbinski C; Jennings LJ; Farooqi M; Gener M; Ginn K; Kam KL; Sasaki K; Kanagal-Shamanna R; Alexandrescu S; Brat D; Lu X
Mod Pathol; 2023 Nov; 36(11):100294. PubMed ID: 37532182
[TBL] [Abstract][Full Text] [Related]
5. Novel
Deland L; Keane S; Bontell TO; Fagman H; Sjögren H; Lind AE; Carén H; Tisell M; Nilsson JA; Ejeskär K; Sabel M; Abel F
Cancer Genomics Proteomics; 2022; 19(6):711-726. PubMed ID: 36316040
[TBL] [Abstract][Full Text] [Related]
6. Fusing the Genetic Landscape of Infantile High-Grade Gliomas.
Szulzewsky F; Cimino PJ
Cancer Discov; 2020 Jul; 10(7):904-906. PubMed ID: 32611733
[TBL] [Abstract][Full Text] [Related]
7. High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experience.
Chiang J; Bagchi A; Li X; Dhanda SK; Huang J; Pinto SN; Sioson E; Dalton J; Tatevossian RG; Jia S; Partap S; Fisher PG; Bowers DC; Hassall TEG; Lu C; Zaldivar-Peraza A; Wright KD; Broniscer A; Qaddoumi I; Upadhyaya SA; Vinitsky A; Sabin ND; Orr BA; Klimo P; Boop FA; Ashford JM; Conklin HM; Onar-Thomas A; Zhou X; Ellison DW; Gajjar A; Robinson GW
Neuro Oncol; 2024 Jan; 26(1):178-190. PubMed ID: 37503880
[TBL] [Abstract][Full Text] [Related]
8. Infant-Type Hemispheric Glioma in a Chinese Girl: A Newly Defined Entity.
Fang Y; Wang YZ; Wei X; Li SM; Chen L
Fetal Pediatr Pathol; 2023 Feb; 42(1):114-122. PubMed ID: 35404193
[TBL] [Abstract][Full Text] [Related]
9. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.
Guerreiro Stucklin AS; Ryall S; Fukuoka K; Zapotocky M; Lassaletta A; Li C; Bridge T; Kim B; Arnoldo A; Kowalski PE; Zhong Y; Johnson M; Li C; Ramani AK; Siddaway R; Nobre LF; de Antonellis P; Dunham C; Cheng S; Boué DR; Finlay JL; Coven SL; de Prada I; Perez-Somarriba M; Faria CC; Grotzer MA; Rushing E; Sumerauer D; Zamecnik J; Krskova L; Garcia Ariza M; Cruz O; Morales La Madrid A; Solano P; Terashima K; Nakano Y; Ichimura K; Nagane M; Sakamoto H; Gil-da-Costa MJ; Silva R; Johnston DL; Michaud J; Wilson B; van Landeghem FKH; Oviedo A; McNeely PD; Crooks B; Fried I; Zhukova N; Hansford JR; Nageswararao A; Garzia L; Shago M; Brudno M; Irwin MS; Bartels U; Ramaswamy V; Bouffet E; Taylor MD; Tabori U; Hawkins C
Nat Commun; 2019 Sep; 10(1):4343. PubMed ID: 31554817
[TBL] [Abstract][Full Text] [Related]
10. Genomic and epigenomic re-categorization of congenital glioblastoma and desmoplastic infantile ganglioglioma.
Gilani A; Siddiq Z; Kissell E; Kasson J; Kleinschmidt-DeMasters BK
Childs Nerv Syst; 2023 Jul; 39(7):1861-1868. PubMed ID: 36707425
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
[TBL] [Abstract][Full Text] [Related]
13. GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
Richardson TE; Tang K; Vasudevaraja V; Serrano J; William CM; Mirchia K; Pierson CR; Leonard JR; AbdelBaki MS; Schieffer KM; Cottrell CE; Tovar-Spinoza Z; Comito MA; Boué DR; Jour G; Snuderl M
J Neuropathol Exp Neurol; 2019 Dec; 78(12):1089-1099. PubMed ID: 31626289
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
Nobusawa S; Hirato J; Yokoo H
Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
[TBL] [Abstract][Full Text] [Related]
15. Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
Olsen TK; Panagopoulos I; Meling TR; Micci F; Gorunova L; Thorsen J; Due-Tønnessen B; Scheie D; Lund-Iversen M; Krossnes B; Saxhaug C; Heim S; Brandal P
Neuro Oncol; 2015 Oct; 17(10):1365-73. PubMed ID: 25795305
[TBL] [Abstract][Full Text] [Related]
16. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinicopathologic features of gliomas harboring NTRK fusions.
Torre M; Vasudevaraja V; Serrano J; DeLorenzo M; Malinowski S; Blandin AF; Pages M; Ligon AH; Dong F; Meredith DM; Nasrallah MP; Horbinski C; Dahiya S; Ligon KL; Santi M; Ramkissoon SH; Filbin MG; Snuderl M; Alexandrescu S
Acta Neuropathol Commun; 2020 Jul; 8(1):107. PubMed ID: 32665022
[TBL] [Abstract][Full Text] [Related]
18. ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non-Small Cell Lung Cancer.
Lin JJ; Ritterhouse LL; Ali SM; Bailey M; Schrock AB; Gainor JF; Ferris LA; Mino-Kenudson M; Miller VA; Iafrate AJ; Lennerz JK; Shaw AT
J Thorac Oncol; 2017 May; 12(5):872-877. PubMed ID: 28088512
[TBL] [Abstract][Full Text] [Related]
19. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
[TBL] [Abstract][Full Text] [Related]
20. Case report: ATIC-ALK fusion in infant-type hemispheric glioma and response to lorlatinib.
Shahab SW; Schniederjan M; Vega JV; Little S; Reisner A; MacDonald T; Aguilera D
Front Oncol; 2023; 13():1123378. PubMed ID: 36910660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
